BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16164981)

  • 1. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
    Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
    Gangat N; Tefferi A; Thanarajasingam G; Patnaik M; Schwager S; Ketterling R; Wolanskyj AP
    Eur J Haematol; 2009 Jul; 83(1):17-21. PubMed ID: 19236446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
    Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent der(9;18) in essential thrombocythemia with JAK2 V617F is highly linked to myelofibrosis development.
    Ohyashiki K; Kodama A; Ohyashiki JH
    Cancer Genet Cytogenet; 2008 Oct; 186(1):6-11. PubMed ID: 18786436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
    Leon A; Staropoli JF; Hernandez JM; Longtine JA; Kuo FC; Dal Cin P
    Leuk Res; 2011 Sep; 35(9):1188-92. PubMed ID: 21376394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
    Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
    Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential thrombocythemia with myelofibrosis transformed into acute myeloid leukemia with der(1;15)(q10;q10): case report and literature review.
    Charafeddine KM; Mahfouz RA; Zaatari GS; Ibrahim GY; Muwakkit SA; Najm ND; Farra CG
    Cancer Genet Cytogenet; 2010 Jul; 200(1):28-33. PubMed ID: 20513531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.
    Tefferi A; Dingli D; Li CY; Dewald GW
    Cancer; 2005 Oct; 104(8):1656-60. PubMed ID: 16104040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
    Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
    Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Der(6)t(1;6)(q21-23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia.
    Dingli D; Grand FH; Mahaffey V; Spurbeck J; Ross FM; Watmore AE; Reilly JT; Cross NC; Dewald GW; Tefferi A
    Br J Haematol; 2005 Jul; 130(2):229-32. PubMed ID: 16029451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC; Ma ES; Wan TS; Yip SF; Chan LC
    Leuk Res; 2008 Jun; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract]   [Full Text] [Related]  

  • 14. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
    Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
    Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
    Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
    Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients.
    Passamonti F; Rumi E; Arcaini L; Boveri E; Elena C; Pietra D; Boggi S; Astori C; Bernasconi P; Varettoni M; Brusamolino E; Pascutto C; Lazzarino M
    Haematologica; 2008 Nov; 93(11):1645-51. PubMed ID: 18790799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2(V617F) and leukemic transformation in myelofibrosis with myeloid metaplasia.
    Mesa RA; Powell H; Lasho T; Dewald G; McClure R; Tefferi A
    Leuk Res; 2006 Nov; 30(11):1457-60. PubMed ID: 16563504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-essential thrombocythemia myelofibrosis and chronic myelomonocytic leukemia can co-exist with complex cytogenetic abnormalities.
    Trakhtenbrot L; Tohami T; Schiby G; Kneller A; Rosenthal E; Rosner E; Amariglio N; Salomon O
    Leuk Res; 2010 Nov; 34(11):e308-10. PubMed ID: 20655587
    [No Abstract]   [Full Text] [Related]  

  • 19. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
    Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
    Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and laboratory investigation of patients with hematologic malignancies harboring der(1;7)(q10;p10)].
    Xu FY; Liu XP; Li CW; Qin S; Sun WC; Cui W; Mi YC; Yang RC; Wang JX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):441-5. PubMed ID: 21811989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.